InterMune is a values-driven organization that works to embody integrity, passion, accountability, creativity and teamwork in bringing new treatments and hope to patients and families around the world. Our focus is research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. Pirfenidone, the only medicine approved for IPF, is marketed by InterMune in the EU and Canada as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States.
View Top Employees from InterMuneWebsite | http://www.intermune.com/ |
Ticker | NASDAQ:ITMN |
Revenue | $70.3 million |
Funding | $125 million |
Employees | 83 (64 on RocketReach) |
Founded | 1998 |
Address | 3280 Bayshore Blvd, Brisbane, California 94005, US |
Phone | (415) 466-2200 |
Fax | (415) 466-2300 |
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Treatment Therapies, Developer Platform, Drug Manufacturing & Research, Software, Therapeutics, Health Care |
Competitors | AstraZeneca México, Bristol Meyers Squibb, Merck, Pfizer |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 5417 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular InterMune employee's phone or email?
The InterMune annual revenue was $70.3 million in 2024.
Russ Kawahata is the Vice President of InterMune.
64 people are employed at InterMune.
InterMune is based in Brisbane, California.
The NAICS codes for InterMune are [54, 541, 32, 32541, 5417, 3254, 325].
The SIC codes for InterMune are [283, 28].